This inventor holds 2 USPTO granted patents. Top assignees: Deutsche Aerospace Ag, Messerschmitt-Bolkow-Blohm Gmbh. Active years: 1992-1996.
Company Filing History:
Years Active: 1992-1996
Title: Gerhard Hauptmann: Innovator in Surgical Laser Technology
Introduction
Gerhard Hauptmann is a notable inventor based in Munich, Germany. He has made significant contributions to the field of surgical laser technology, holding 2 patents that showcase his innovative approach to medical treatments. His work focuses on improving the efficacy and safety of laser applications in biological tissue.
Latest Patents
Hauptmann's latest patents include a "Process for operating a laser" and a "Surgical laser instrument." The first patent describes a method for interstitial thermotherapeutic treatment of biological tissue. This process involves guiding laser radiation into the tissue through a fiber optic waveguide, with a continuous or stepwise reduction of laser power during the radiation period to generate coagulation necrosis. The second patent outlines a surgical laser instrument designed for alternating constant cutting and no-contact coagulating of biological tissue. This instrument utilizes fiber-optically guided laser irradiation, where the emitted radiation from the pyrolytic glowing of carbonized biological tissue is detected and controlled to ensure it remains below the destruction threshold of the fiber-optic light guide.
Career Highlights
Throughout his career, Hauptmann has worked with prominent companies such as Deutsche Aerospace AG and Messerschmitt-Bolkow-Blohm GmbH. His experience in these organizations has contributed to his expertise in laser technology and its applications in surgery.
Collaborations
Hauptmann has collaborated with notable individuals in his field, including Stefan Hessel and Frank Frank. These partnerships have likely enhanced his research and development efforts in surgical laser innovations.
Conclusion
Gerhard Hauptmann's contributions to surgical laser technology reflect his dedication to advancing medical treatments. His patents demonstrate a commitment to improving patient outcomes through innovative solutions.